Showing results (1-10 of 196) with videos related to
Sort By:
Pageof 20
Clinical Science (London, England : 1979)|May 1, 1982
Relationship between hepatic cholesterol synthesis and biliary cholesterol secretion in man: hepatic cholesterol synthesis is not a major regulator of biliary lipid secretionP N Maton, A Reuben, R H DowlingLancet (London, England)|December 24, 1977
Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of actionP N Maton, G M Murphy, R H DowlingGut|December 1, 1980
Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acidP N Maton, G M Murphy, R H DowlingClinical Science (London, England : 1979)|July 1, 1985
Bile lipid secretion in obese and non-obese individuals with and without gallstonesA Reuben, P N Maton, G M Murphy, et al.British Medical Journal|June 10, 1978
Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stonesJ H Iser, P N Maton, G M Murphy, et al.European Journal of Clinical Investigation|August 1, 1980
Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acidsP N Maton, H J Ellis, M J Higgins, et al.Medicine|March 1, 1982
Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrenceP N Maton, J H Iser, A Reuben, et al.Gut|May 1, 1982
Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstonesT J Meredith, G V Williams, P N Maton, et al.Drugs|July 1, 1996
Zollinger-Ellison syndrome. Recognition and management of acid hypersecretionP N MatonPageof 20